Articles from Vielight Inc.

University of Toronto Researchers Report Real-Time Brain Fluid Modulation Using Vielight Photobiomodulation
Published in Brain Stimulation, the Baycrest/Rotman team used fMRI to show rapid CSF dynamics changes after brief pulsed PBM sessions.
By Vielight Inc. · Via GlobeNewswire · January 8, 2026
Vielight Inc. Enhances Meditation Practices with Groundbreaking Technology and Announces New Neuroscience of Meditation Summit
Toronto, Ontario, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Toronto, ON – [ Oct. 1, 2025 ] – Vielight Inc., a global leader in photobiomodulation (PBM) and neuro-stimulation technology, is excited to announce a renewed focus on meditation and the upcoming Neuroscience of Meditation Summit, taking place at the Schwartz Reisman Innovation Campus in Toronto on October 24, 2025.
By Vielight Inc. · Via GlobeNewswire · October 1, 2025
Vielight Unveils the First Photobiomodulation-Based Vagus Nerve Stimulation Device Following Patent Approval
A non-electrical, pulsed near-infrared approach to the cervical vagus—hands-free and research-ready.
By Vielight Inc. · Via GlobeNewswire · September 16, 2025
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
Season-long analyses in collegiate athletes report promising signals on cognitive performance and recovery; adoption is also growing in combat sports.
By Vielight Inc. · Via GlobeNewswire · September 2, 2025
Vielight Unveils Neuro Pro 2: The Most Advanced Transcranial Photobiomodulation Device to Date
TORONTO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in brain health technology and photobiomodulation (PBM), proudly announces the launch of the Neuro Pro 2, its most advanced transcranial PBM device yet. Engineered to meet the needs of neurofeedback practitioners, researchers, biohackers, meditators, and anti-aging professionals, the Neuro Pro 2 sets a new standard in non-invasive brain stimulation.
By Vielight Inc. · Via GlobeNewswire · February 5, 2025
Vielight Starts Clinical Trial to Study Photobiomodulation Device Treatment for Post-Covid Cognitive Impairment
Now recruiting eligible participants for study in the United States
By Vielight Inc. · Via GlobeNewswire · July 26, 2023
Vielight Founder, Dr. Lew Lim Granted a Patent for Artificial Intelligence (AI) Brain Stimulation & Assigns to Vielight Inc.
New technology will enable a new level of personalization in light therapy
By Vielight Inc. · Via GlobeNewswire · July 13, 2023
Vielight Inc. Receives Health Canada Approval for Treatment of Covid-19 with Near Infrared Device Technology
Approval from Canada’s Top Federal Health Agency Followed Positive Clinical Trial Results
By Vielight Inc. · Via GlobeNewswire · May 25, 2023
Articles from Vielight Inc. | The Union Democrat